Dechra Pharmaceuticals PLC Stock – Fundamental Analysis

Price
–
–
Delisted
Reason: Fusion / Übernahme Delisting date: –

Not enough price data available yet.

Fundamental Data & Ratios (Balance sheet update: 10/28/2023)

Balance Sheet Total Assets 1,569,000,000.00 ROE –
Balance Sheet Total Equity 755,000,000.00 ROA –
Cashflow Capital Expenditures -77,600,000.00 P/FCF –
Cashflow Free Cash Flow 45,300,000.00 – –
Cashflow Operating Cash Flow 122,900,000.00 P/CF –
Income Earnings per Share (diluted) -0.25 Div. Yield –
Income Net Income -27,900,000.00 P/E –
Income Shares Outstanding 113,480,000.00 P/B –
Income Total Revenue 761,500,000.00 P/S –

Ratios calculated on: –

Company Description

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.dechra.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more